Cti Biopharma Corp buy Needham & Company LLC
Start price
06.03.23
/
50%
€4.56
Target price
06.03.24
€8.42
Performance (%)
83.36%
End price
07.03.24
-
Summary
This prediction is currently being closed. With a performance of 83.36% the BUY prediction by Needham___Company_LL is a big success. Needham___Company_LL has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m | 1y | 3y |
|---|---|---|---|---|
| Cti Biopharma Corp | - | - | - | - |
| iShares Core DAX® | -1,74 % | -10,68 % | -0,89 % | 48,09 % |
| iShares Nasdaq 100 | -2,58 % | -3,32 % | 11,12 % | 74,13 % |
| iShares Nikkei 225® | -1,16 % | -9,36 % | 23,69 % | 48,88 % |
| iShares S&P 500 | -1,42 % | -3,76 % | 7,19 % | 57,43 % |
Comments by Needham___Company_LL for this prediction
In the thread Cti Biopharma Corp diskutieren
CTI BioPharma Corp. (NASDAQ: CTIC) had its "buy" rating re-affirmed by analysts at Needham & Company LLC. They now have a $9.00 price target on the stock.
Ratings data for CTIC provided by MarketBeat
In the thread Trading Cti Biopharma Corp
Die von Needham___Company_LL gewählte maximale Laufzeit wurde überschritten